Kalaris Therapeutics, Inc.

Ownership Transactions Reported by 30 Insiders

Symbol
KLRS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
628 Middlefield Road, Palo Alto, CA

Insiders trading volume in the past year

Kalaris Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Samsara BioCapital GP, LLC 10%+ Owner $115M Mar 18, 2025
Morana Jovan-Embiricos Director $21.1M Apr 10, 2025
David Hallal Director $15.6M Apr 10, 2025
Ansbert Gadicke Director, 10%+ Owner $11.2M Jul 28, 2022
ElevateBio, LLC Director, 10%+ Owner $11.2M Jul 28, 2022
Gilead Sciences, Inc. 10%+ Owner $11.2M Jun 27, 2023
Vikas Sinha Officer Title: President, Chief Financial Officer and Chief Executive Officer, Director, 10%+ Owner $7.8M -$28.9K -0.37% Feb 21, 2025
F2 MG Ltd Director, 10%+ Owner $6.59M Jul 28, 2022
Napoleone Ferrara Director $5.08M Apr 10, 2025
Samir Chandrakant Patel Director $3.55M Apr 10, 2025
John Robert Wilson Director $2.12M May 25, 2021
Juan Vera Director $1.91M Jun 6, 2024
Diana Brainard Chief Executive Officer, Director $397K -$60K -13.1% Nov 19, 2024
Agustin Melian Chief Medical Officer $304K Oct 4, 2021
Jeroen B. Van Beek Chief Commercial Officer $224K Nov 16, 2022
Edward Miller General Counsel $217K -$10.3K -4.54% Feb 21, 2025
Malcolm Brenner Director $209K Jun 6, 2024
Cintia Piccina Chief Commercial Officer $98.6K Jul 3, 2023
Ercem Atillasoy Officer $88.1K Oct 20, 2022
Jeffrey Bornstein Director $87.3K Jun 6, 2024
Ann M. Leen Chief Scientific Officer $83.2K Aug 16, 2022
Derek N. Adams Director $55.5K Jun 6, 2024
Shawn Tomasello Director $55.5K Jun 6, 2024
Matthew Feinsod Chief Medical Officer $40.6K Apr 10, 2025
Srinivas Akkaraju Director, 10%+ Owner $36.1K Apr 10, 2025
Brett Hagen Chief Accounting Officer $17.3K -$16.2K -48.5% Apr 10, 2025
Anthony P. Adamis Director Apr 10, 2025
Michael Dybbs Director Apr 10, 2025
Andrew Oxtoby President and Chief Executive Officer, Director Apr 10, 2025
Leone D. Patterson Director Apr 10, 2025

Recent Insider Transactions by Companies or Individuals for Kalaris Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.